Given the discernible expression of ACKR3 in MVP areas of GBM tumors, its contribution to the angiogenic mechanisms in glioma patients and its interplay with CXCR4 definitely warrant further investigation. This evidence concerns the gene ACKR3 and central nervous system cancer.